Biotech Values

[BTH]

SRPT Wednesday 8:00 am conference call

CAMBRIDGE, MA, Oct 02 (Marketwire) --
Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative
RNA-based therapeutics, announced today it will hold a conference call at
8:00 a.m. EDT (5:00 a.m. PDT) on Wednesday, October 3, 2012 to discuss
48-week results from its Phase IIb study evaluating eteplirsen for the
treatment of Duchenne muscular dystrophy (DMD).

The conference call may be accessed by dialing 866.356.3093 for domestic
callers and 617.597.5381 for international callers. The passcode for the
call is 93880948. Please specify to the operator that you would like to
join the "Sarepta Therapeutics 48-Week Results Call." The conference call
will be webcast live under the events section of Sarepta's website at
www.sareptatherapeutics.com and will be archived there following the call
for 90 days. Please connect to Sarepta's website several minutes prior to
the start of the broadcast to ensure adequate time for any software
download that may be necessary.

About Sarepta Therapeutics